Nanotechnology-enhanced materials and smart implants are emerging technologies that have shown promise in addressing various challenges in general surgery, including infection management, oncologic staging, and complication monitoring. In this systematic review, we aimed to examine the safety and efficacy of these technologies compared with conventional methods in patients undergoing general surgical procedures. A comprehensive search was conducted in MEDLINE (via PubMed), Embase, Scopus, Web of Science, the Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, WHO ICTRP, IEEE Xplore/Inspec, and Google Scholar according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, using standardized keywords related to nanotechnology, surgery, and clinical outcomes. The included studies were categorized according to intervention class and procedural type. Risk of bias was assessed using RoB 2 for randomized trials and ROBINS-I for nonrandomized studies, while outcome certainty was evaluated using GRADE. Nine eligible studies were included, comprising a total of 2,250 participants (infection prevention: 974; mapping/staging: 1,244; sensing: 32 drain-fluid samples). Due to heterogeneity among the studies, a meta-analysis could not be performed, and the results were therefore synthesized narratively. Silver-based topical creams and dressings demonstrated early bacterial clearance and improved wound healing. Carbon nanoparticle (CNP) suspensions enhanced lymph node detection sensitivity and preserved parathyroid hormone in thyroid cancer and nearly doubled sensitivity to micrometastatic lymph nodes in gastric cancer. Silver-ion-impregnated tracers in breast cancer showed comparable sensitivity for sentinel lymph node detection. Silver-ion-impregnated meshes showed no significant difference compared with conventional meshes. Overall, adverse effects were minimal or absent. In conclusion, nanotechnology-enhanced materials and smart implants show substantial potential to improve infection prevention, oncologic staging, and perioperative monitoring in general surgery, with minimal adverse effects. Silver-based topical antimicrobials, CNP suspensions, superparamagnetic iron oxide tracers, and innovative biosensor technologies were either comparable or superior to conventional alternatives. However, a clear knowledge gap regarding long-term outcomes and the heterogeneity of comparators highlights the need for larger, rigorously designed studies to guide clinical adoption.
smart implantsgeneral surgerysurgical site infection preventionlymphatic mapping
Advanced Health Science and Technology Journal · مجلد 1 (2) · 86-91
Abstract Background: Chronic rhinosinusitis (CRS) is a persistent inflammatory disorder of the paranasal sinuses, significantly impairing quality of life (QoL). While corticosteroids are central to CRS management, evidence from Saudi Arabia remains limited. Objectives: This study aimed to (1) evaluate the improvement in CRS symptoms following corticosteroid therapy, (2) compare the effectiveness of intranasal versus systemic corticosteroids, (3) analyze side effects, and (4) assess the impact of therapy on QoL among Saudi patients. Methodology: A cross-sectional descriptive study was conducted among Saudi adults with physician-diagnosed CRS and prior corticosteroid use. Data were collected via an online questionnaire incorporating the validated Sino-Nasal Outcome Test-22. Descriptive and inferential statistics were performed using SPSS. Results: Of 201 participants, 78.6% had a CRS diagnosis and 70.6% used intranasal corticosteroids. Most patients (88.6%) reported moderate-to-complete improvement in symptoms, with intranasal sprays demonstrating significantly greater effectiveness compared to oral corticosteroids ( P < 0.001). Adverse effects were rare, with 95.5% reporting none; headaches (2.5%) and nausea (1.0%) were the most common. Quality-of-life scores improved, although persistent issues included nasal congestion, loss of smell, and daily irritation. Conclusion: Corticosteroid therapy–particularly intranasal sprays–is highly effective and well-tolerated in Saudi patients with CRS. These findings align with global evidence and highlight the need for patient education and improved adherence to optimize outcomes within the Saudi healthcare context.
Frontiers in Pharmacology · مجلد 15 · 1412245-1412245
Honeybees have been helpful insects since ancient centuries, and this benefit is not limited to being a honey producer only. After the bee stings a person, pain, and swelling occur in this place, due to the effects of bee venom (BV). This is not a poison in the total sense of the word because it has many benefits, and this is due to its composition being rich in proteins, peptides, enzymes, and other types of molecules in low concentrations that show promise in the treatment of numerous diseases and conditions. BV has also demonstrated positive effects against various cancers, antimicrobial activity, and wound healing versus the human immunodeficiency virus (HIV). Even though topical BV therapy is used to varying degrees among countries, localized swelling or itching are common side effects that may occur in some patients. This review provides an in-depth analysis of the complex chemical composition of BV, highlighting the diverse range of bioactive compounds and their therapeutic applications, which extend beyond the well-known anti-inflammatory and pain-relieving effects, showcasing the versatility of BV in modern medicine. A specific search strategy was followed across various databases; Web of sciences, Scopus, Medline, and Google Scholar including in vitro and in vivo clinical studies.to outline an overview of BV composition, methods to use, preparation requirements, and Individual consumption contraindications. Furthermore, this review addresses safety concerns and emerging approaches, such as the use of nanoparticles, to mitigate adverse effects, demonstrating a balanced and holistic perspective. Importantly, the review also incorporates historical context and traditional uses, as well as a unique focus on veterinary applications, setting it apart from previous works and providing a valuable resource for researchers and practitioners in the field.
International Journal of Pharmaceutics X · مجلد 7 · 100232-100232
Diabetes mellitus (DM) is the most prevalent cause of diabetic retinopathy (DRP). DRP has been recognized for a long time as a microvascular disease. Many drugs were used to treat DRP, including vildagliptin (VLD). In addition to its hypoglycemic effect, VLD minimizes ocular inflammation and improves retinal blood flow for individuals with type 2 diabetes mellitus. Nevertheless, VLD can cause upper respiratory tract infections, diarrhea, nausea, hypoglycemia, and poor tolerability when taken orally regularly due to its high water solubility and permeability. Effective ocular administration of VLD is achieved using solid lipid nanoparticles (SLNPs), which improve corneal absorption, prolonged retention, and extended drug release. Ocuserts (OCUs) are sterile, long-acting ocular dosage forms that diminish the need for frequent dosing while improving residence time and stability. Therefore, this study intends to develop VLD solid lipid nanoparticle OCUs (VLD-SLNPs-OCUs) to circumvent the issues commonly associated with VLD. SLNPs were prepared using the double-emulsion/melt dispersion technique. The optimal formula has been implemented in OCUs. Optimization and development of VLD-SLNPs-OCUs were performed using a Box-Behnken Design (BBD). VLD-SLNPs-OCUs loading efficiency was 95.28 ± 2.87%, and differential scanning calorimetry data (DSC) showed the full transformation of VLD to an amorphous state and the excellent distribution in the prepared OCUs matrices. The in vivo release of VLD from the optimized OCUs after 24 h was 35.12 ± 2.47%, consistent with in vitro drug release data of 36.89 ± 3.11. The optimized OCUs are safe to use in the eye, as shown by the ocular irritation test. VLD-SLNPs-OCUs provide extended VLD release, an advantageous alternative to conventional oral dose forms, resulting in fewer systemic adverse effects and less variation in plasma drug levels. VLD-SLNPs-OCUs might benefit retinal microvascular blood flow beyond blood glucose control and may be considered a promising approach to treating diabetic retinopathy.
vildagliptinsolid lipid nanoparticlesOcusertocular drug delivery
Oral squamous cell carcinoma (OSCC) is a highly malignant and invasive tumor with significant mortality and morbidity. Current treatment modalities such as surgery, radiotherapy, and chemotherapy encounter significant limitations, such as poor targeting, systemic toxicity, and drug resistance. There is an urgent need for novel therapeutic strategies that offer targeted delivery, enhanced efficacy, and reduced side effects. The advent of lipid-based nanoparticles (LNPs) offers a promising tool for OSCC therapy, potentially overcoming the limitations of current therapeutic approaches. LNPs are composed of biodegradable and biocompatible lipids, which minimize the risk of toxicity and adverse effects. LNPs can encapsulate hydrophobic drugs, improving their solubility and stability in the biological environment, thereby enhancing their bioavailability. LNPs demonstrate significantly higher ability to encapsulate lipophilic drugs than other nanoparticle types. LNPs offer excellent storage stability, minimal drug leakage, and controlled drug release, making them highly effective nanoplatforms for the delivery of chemotherapeutic agents. Additionally, LNPs can be modified by complexing them with specific target ligands on their surface. This surface modification allows the active targeting of LNPs to the tumors in addition to the passive targeting mechanism. Furthermore, the PEGylation of LNPs improves their hydrophilicity and enhances their biological half-life by reducing clearance by the reticuloendothelial system. This review aims to discuss current treatment approaches and their limitations, as well as recent advancements in LNPs for better management of OSCC.
oral squamous cell carcinomalipid nanoparticlestargeted drug deliverychemotherapy
Disease-modifying anti-rheumatic drugs (DMARDs) is a class of anti-rheumatic medicines that are frequently prescribed to patients suffering from rheumatoid arthritis (RA). Methotrexate, sulfasalazine, hydroxychloroquine, and azathioprine are examples of non-biologic DMARDs that are being used for alleviating pain and preventing disease progression. Biologic DMARDs (bDMARDs) like infliximab, rituximab, etanercept, adalimumab, tocilizumab, certolizumab pegol, and abatacept have greater effectiveness with fewer adverse effects in comparison to non-biologic DMARDs. This review article delineates the classification of DMARDs and their characteristic attributes. The poor aqueous solubility or permeability causes the limited oral bioavailability of synthetic DMARDs, while the high molecular weights along with the bulky structures of bDMARDs have posed few obstacles in their drug delivery and need to be addressed through the development of nanoformulations like cubosomes, nanospheres, nanoemulsions, solid lipid nanoparticles, nanomicelles, liposome, niosomes, and nanostructured lipid carrier. The main focus of this review article is to highlight the potential role of nanotechnology in the drug delivery of DMARDs for increasing solubility, dissolution, and bioavailability for the improved management of RA. This article also focusses on the different aspects of nanoparticles like their applications in biologics, biocompatibility, body clearance, scalability, drug loading, and stability issues.
Testicular dysfunction is a common adverse effect of cisplatin (CIS) administration as a chemotherapeutic drug. The current study has outlined the role of micro-RNAs (miR-155 and 34c) in CIS-induced testicular dysfunction and evaluated the protective effect of N-acetyl cysteine (NAC) and/or l-arginine (LA). Seven groups of Albino rats were used for this study. The control (C) group received physiological saline; the CIS group was injected CIS (7 mg/kg IP, once) on day 21 of the experiment; the NAC group was administered NAC (150 mg/kg intragastric, for 28 days); and the LA group was injected LA (50 mg/kg IP, for 28 days). NAC+CIS, LA+CIS, and NAC+LA+CIS groups received the above regime. CIS significantly reduced serum testosterone, LH, and FSH concentrations with decline of testicular enzyme activities. CIS caused significant elevation in testicular oxidative-stress biomarkers, inflammation-associated cytokines, and apoptosis markers, along with overexpression of miR-155 and low miR-34c expression. Additionally, marked testicular degenerative changes were observed in the examined histological section; a significant decrease in the expression of PCNA with significant increase in expressions of F4/80 and BAX was confirmed. The administration of NAC or LA upregulated testicular functions and improved histopathological and immunohistochemical changes as well as miRNA expression compared with the CIS-administered group. Rats receiving both NAC and LA showed a more significant ameliorative effect compared with groups receiving NAC or LA alone. In conclusion, NAC or LA showed an ameliorative effect against CIS-induced testicular toxicity and dysfunction through the regulation of antioxidant, anti-inflammatory, and antiapoptotic markers and via modulating miR-155 and miR-34c expression.
BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · 119-131
Background: Internal fixation of mandibular fractures with Titanium (Ti) plates has become the gold standard for treatment in the adult population. Unfortunately, Ti plates had a tendency to undergo corrosion causing inflammation of surrounding bone that often led to failure of treatment. Magnesium (Mg) based newer materials such as WE43 alloy have been studied extensively for its ability to resorb in the presence of living tissue. Mg based WE43 alloy has demonstrated superior corrosion resistance and mechanical properties comparable to standard Titanium devices. The aim of this systematic review was to know whether WE43 based fixation devices can be used as an alternative to Ti based fixation devices for osteosynthesis. Materials and Methods: PubMed, Cochrane, Google Scholar, Web of Science, were searched to find the studies comparing the WE43 fixation devices and Ti based fixation devices for osteosynthesis. No filters were applied. Search terms related to WE43, titanium, fixation, osteosynthesis, corrosion resistance, fracture fixation, complications of treatment, etc, were used to search relevant studies. Data extraction, quality assessment, and summary synthesis for treatment outcomes including corrosion resistance,stability, osteosynthesis, adverse effects were carried out. Results: 5 studies consisting of 3 in-vivo animal studies and 2 clinical trials were included after the screening of search results. In the animal studies, i)16 rabbit specimens were divided into 2 groups -Group I received Ti based implants, while Group II received Mg based WE43 implants. ii)10 beagle dogs were divided into 2 groups and evaluated at 4, 12, and 24 weeks after implant placement. iii)18 hemi mandibles of sheep were tested to check the outcome of fracture fixation between Mg and Ti based fixation devices. Group I used Ti1.0, Group II used Mg 1.75, and Group III used Mg 1.5. In the clinical trials, i) fixation of mandibular head fracture was done in 31 using WE43 screws and 29 patients using Mg screws and ii) 11 patients treated with Mg compression screws and 10 patients with Ti compression screws. Conclusions: Comparison of properties of WE43 with Ti in the animal models has shown a non-inferiority of the Mg based material. Biomechanically, the human studies revealed promising results concerning the use of WE43 as a potential alternative to Ti in fracture fixation. Further evaluation is warranted under biomechanical loading conditions to verify the clinical performance of the material.
Both adults and children are regularly afflicted by infectious illnesses. We now have a better understanding of their epidemiology, pathophysiology, prevention, and treatment because of new diagnostic techniques. Recently, emerging infections have surfaced, prompting health officials to issue warnings. Furthermore, novel anti-microbial therapies have been identified; however, because of the potential for adverse effects on antimicrobial resistance, it is critical to understand when to utilize these therapies in order to prevent overuse and misuse. In addition, new vaccinations have entered the market, and it is crucial that medical professionals understand how they may affect public health. Also the use of prebiotics and probiotics has emerged now as a preventive measure for pediatric infectious diseases.
Journal of Advanced Trends in Medical Research · مجلد 1 (3) · 784-790
Abstract Background: Traumatic brain injury (TBI) in children is still a major concern amongst healthcare worldwide as it causes raised morbidity and mortality rate. Identification of TBI cases is therefore paramount in treatment with diagnostic imaging techniques such as the computed tomography (CT) and magnetic resonance imaging (MRI) amongst others. However, deciding between the two methods has been a challenge since radiation exposure by CT and the limitation of MRI, which include longer time for scan and most importantly, need for use of sedation amongst children. This review aims at analysing and comparing accuracy of CT and MRI in diagnosing paediatric TBI; the effects of the two MRI scans on prognosis and the contribution of the two scans in management decision-making. Furthermore, the views on safety issues connected with radiation in CT as well as whether the modern MRI methods can improve the diagnostic potential without safety issues are also discussed. Methods: A literature search using the PubMed, Scopus and Google Scholar databases was done with terms such as ‘point of care’, ‘clinical decision support’, ‘decision support system’ was used with an emphasis on articles published in the past 15 years. Article titles used were ‘paediatric traumatic brain injury’, ‘CT in paediatric TBI’, ‘MRI in paediatric TBI’ and ‘diagnostic accuracy of imaging in TBI’. The review of articles involved only patients aged between 0 and 18 years diagnosed with TBI through CT or MRI that provided data on diagnostic accuracy, clinical management and safety considerations. Results: CT is used in the management of acute TBI because it is fast and widely available, especially for instance in emergency situations. MRI, however, has the advantages of producing higher sensitivity in identification of diffuse axonal injuries and less evident pathologies of the brain that may not be identified in a CT. However, MRI has limitations such as long time to perform a scan, is expensive and requires administration of sedatives to children making it less suitable for use in the acute care settings. Third, despite its effectiveness, CT exposes the patient to radiation that increases his/her chances of getting cancer especial if the patient is a child. Newer techniques in MRI have emerged which enhance the capacity of diagnosis of paediatric TBI and its further management and prognosis; these are the diffusion tensor imaging and susceptibility-weighted imaging. Conclusions: CT and MRI should both be used in the evaluation of paediatric TBI because they each provide information that the other cannot. CT scan has remained the primary imaging modality in the acute setting because of the speed in availability and to assess the critical lesions, whereas MRI offers a detailed examination of TBI important in the post-acute phase. This review is helpful in establishing possible guidelines that will help in the use of these imaging techniques in paediatric TBI that will enhance the detection of the injury without exposing the patients to additional harm. More investigation is, therefore, required to standardise the techniques and protocols that improve the efficiency of imaging procedures for therapeutic processes, while avoiding adverse effects such as radiation hazards.
The need for novel approaches to the treatment of colon cancer, a common and deadly disease, is universal. In this compilation, we look at how polymeric nanoparticles (Polymeric nanoparticles) could be used to treat colon cancer. Advantages of Polymeric nanoparticles in Fig.hting this disease include targeted medication administration, enhanced therapy efficacy, and fewer adverse effects. Their impact on cancer treatment is huge. Drug release and miRNA play crucial roles in this struggle by enabling early disease identification, individualised treatment strategies, and bolstering PONP mechanisms. The most up-to-date developments in the use of biomarkers in the diagnosis and prognosis of colon cancer are also discussed. Biomarkers used in toxicology range from genes to epigenomes to molecules. Better patient outcomes can be expected when biomarkers are used in conjunction with Polymeric nanoparticles for personalised treatment and cytotoxicity assessment. This strategy has the potential to completely transform cancer care by putting the needs of each patient first. Combining therapeutic and diagnostic capabilities inside a single nanoparticle system, the use of drug delivery and miRNA elevates the concept of theranostic applications employing Polymeric nanoparticles in colon cancer. This novel method enables toxicological and diagnostic capabilities to visualise and monitor colon cancer treatment with tailored drug administration. Additional research and clinical validation are necessary to implement these developments in clinical practise. There is reason to be optimistic about the future of cancer therapy when Polymeric nanoparticles are used in conjunction with standard medical care.
polymeric nanoparticlescolon cancerbiomarkerstargeted drug delivery
This study aims to investigate and address the issue of emergency department (ED) overcrowding, a significant problem worldwide. The study seeks to understand the impacts of ED overcrowding on emergency medical healthcare services and patient outcomes. This systematic review follows the PRISMA flow diagram and the guidelines of the Cochrane Handbook. We systematically reviewed the causes and solutions of emergency department overcrowding. We went through Google Scholar, the National Center for Biotechnology Information, the British Medical Journal, Science Direct, Ovid, Cochrane, the Saudi Journal of Emergency Medicine, Medline, and PubMed as databases. Our criteria were articles done in Saudi Arabia from 2012 to 2022. One hundred and ninety-six (196) research papers were extracted; only 28 articles met our paper inclusion-exclusion criteria. The result of these papers regarding causes, consequences, and solutions was that non-urgent and returned visits lacked knowledge of PHC, triad, and telemedicine services. Prolonged LOS is due to slow bed turnover, laboratory and consultation time, and physical response to the final decision resulting in burnout staff, wrong diagnoses, and management plans. The crowding issues can be resolved by awareness, PHC access, triad systems, and technological and telemedicine services. High demand for emergency treatment should not be a hindrance to quality treatment. Physical, technological, and strategic measures should be put in place to fight the crowding problem in EDs in Saudi Arabia, as it may cause adverse effects such as transmission of diseases and death of patients.
emergency department overcrowdingprimary care accesstriage systemstelemedicine
Journal of Biomolecular Structure and Dynamics · مجلد 43 (4) · 1804-1817
NSAIDs represent a mainstay in pain and inflammation suppression, and their actions are mainly based on inhibiting COX-1 and COX-2 enzymes.Due to the adverse effects of these drugs, especially on the stomach and heart, scientists efforts have been directed to manufacture selective COX-2 without cardiovascular side effects and with minimal effects on the stomach. The cardiovascular side effects are thought to be related to the chemical composition rather than mechanism of action of these drugs.Novel pyridopyrimidines, 9a-j, were prepared and their chemical structures were confirmed by NMR, mass and IR Spectra, and elemental analysis. The effect of the 9a-j compounds on COX-1 and COX-2 was assessed and it was found that 2-hydrazino-5-(4-methoxyphenyl)-7-phenyl-3H-pyrido[2,3-d)pyrimidin-4-one (9d) was the most potent COX-2 inhibitor (IC50 = 0.54 uM) compared to celecoxib (IC50 = 1.11 uM) with selectivity indices of 6.56 and 5.12, respectively.The in vivo inhibition of paw edema of novel compounds 9a-j was measured using carrageenan-induced paw edema method, and that 2-hydrazino-5-(4-methoxyphenyl)-7-phenyl-3H-pyrido[2,3-d)pyrimidin-4-one (9d) showed the best inhibitory activity in comparison with the other compounds and celecoxib.The gastroprotective effect of the potent derivatives 9d, 9e, 9f, 9 g and 9h was investigated. 2-Hydrazino-5-(4-methoxyphenyl)-7-phenyl-3H-pyrido[2,3-d)pyrimidin-4-one (9d) and 7-(chlorophenyl)-hydrazino-5-(4-methoxyphenyl)-3H-pyrido[2,3-d)pyrimidin-4-one (9e) showed ulcer indices comparable to celecoxib (1 and 0.5 vs 0.5, respectively). Docking studies were carried out and they confirmed the mechanistic action of the designed compounds
Introduction Dermal filling for aesthetics and facial rejuvenation is one of the most common aesthetic procedures, with hyaluronic acid (HA) being the most commonly used filler due to its high safety profile. Nevertheless, adverse effects have been reported that people should be aware of before the procedure. This study aims to assess Saudi Arabians' awareness of dermal fillers, their side effects, and information sources. Methods This cross-sectional study used an online questionnaire to determine participants' level of knowledge, from January 2, 2022, to February 19, 2023. Statistical analysis and ordinal logistic regression were used to assess the respondents' knowledge of dermal fillers and other parameters. Results Of the 1,208 respondents, 290 reported using fillers, and 44% reported that complications were mentioned to them before the procedure. The results also showed that the primary source of information was social media (44.8%), followed by the Internet, physicians, and books. Respondents to whom physicians explained complications reported bruising, bluish discoloration at the injection site, redness, swelling, and accumulation of body cells under the skin, as discussed with them. Bruising and bluish discoloration were the significantly reported complications in people who received fillers, whereas lumps, epistaxis, ulceration/loss of skin, and swelling/accumulation were reported in those who did not receive fillers. Conclusion Although some adverse effects may occur with HA, its enormous advantages led to its use in facial rejuvenation. With social media as a major source of information, many respondents reported unlikely adverse effects as common ones, suggesting that information sources need to be corrected by physicians to raise awareness of the adverse effects of cosmetic procedures and enhance informed decision-making by patients.
The coronavirus disease of 2019 (COVID-19) pandemic has resulted in an unprecedented circumstance that has never previously occurred. This has caused the Saudi Arabian people to recognize the necessity of preventive measures and explore alternative systems, such as using natural products (NPs), for treating their infection. Therefore, the specific objectives of this study were to explore the factors that influence the selection of NPs for COVID-19 management and to know the outcome of using NPs in COVID-19 infection management. This observational cross-sectional study was conducted in Saudi Arabia between February and April 2022. The validated pretested questionnaire was distributed among different regions of the country via a purposive snowball sampling procedure. Both descriptive statistics and stepwise regression analyses were carried out to evaluate the parameters related to the use of medicinal plants for the prevention of COVID-19 and the treatment of respiratory symptoms during the pandemic. The data obtained were statistically analyzed using IBM SPSS Statistics for Windows, version 25 (IBM Corp., Armonk, NY, USA). Of the 677 participants, 65% reported using NPs for themselves or family members during COVID-19. Utilizing NPs is always given priority by a significant (p < 0.001) percentage of survey respondents. Further, a highly significant (p < 0.001) percentage of participants felt that using NPs reduced their COVID-19 symptoms without having any remarkable (p < 0.001) adverse effects. Family and friends (59%) were the most frequent sources of information about utilizing NPs, followed by personal experience (41%). Honey (62.7%) and ginger (53.8%) were the most utilized NP among participants. Moreover, black seeds, garlic and turmeric were used by 40.5%, 37.7% and 26.3% of the surveyors, respectively. Those who used NPs before COVID-19 were 72.9% more likely to use them during COVID-19. NPs are more likely to be used by 75% of people who live in the central part of the country and whose families prefer it. This is true even if other factors are considered, such as the practice of using NPs along with traditional therapies and the fact that some participants’ families prefer it. Our findings show that NPs were commonly used to treat COVID-19 infection among Saudi Arabian residents. Close friends and family members mainly encouraged the use of NPs. Overall, the use of NPs was high among those who participated in our study; such practices are strongly impacted by society. It is essential to promote extensive studies to improve the recognition and accessibility of these products. Authorities should also educate the people about the benefits and risks of using commonly used NPs, especially those reported in this study.
COVID-19 pandemicnatural productsmedicinal plantsherbal medicine